The Dipharma Group is a global CDMO and a leading manufacturer of APIs, New Chemical Entities (NCE), and advanced Intermediates for Generic and Contract Manufacturing markets, offering about 40 APIs with DMFs registered worldwide.  

Thanks to a workforce of about 600 skilled and highly committed employees, supported by four state-of-the-art CGMP facilities, located in the U.S.A. and Italy, plus commercial sales offices in Italy, the U.S.A. and China, Dipharma is strategically positioned to meet the dynamic needs of the pharmaceutical industry.  

Our fully-equipped Research and Development Centers, supported by the internal Intellectual Property department, drive innovation by developing cutting-edge chemical processes and crystalline forms tailored to meet the unique requirements of our customers. 
Since 1970, Dipharma has managed to achieve a positive unbroken record of inspections by the major Regulatory Agencies and the CGMP manufacturing sites are equipped to supply quantities from laboratory to industrial scale, covering the entire lifecycle of a pharmaceutical substance. 
 

Dipharma's core technologies are: High-pressure hydrogenation, Nitration, Nitroesterification, Azide chemistry, Borane reductions, Cross-coupling reactions, Curtius reaction, Dissolving metal reduction, Enzymatic chemistry, Epichlorohydrin chemistry, Hoffman reaction, Hydrogen peroxide oxidations, Carbohydrate chemistry, Enantioselective reactions, Use of nitroalkanes (Henry reaction), Wolff-Kishner reduction. 

The Dipharma Group has the right size and variety of scale-up capabilities to act as a global player and manage processes efficiently while offering flexibility and agility to promptly solve any challenge. 
Experience you can trust 

 Dipharma 集團是一家全球性的醫(yī)藥合同研發(fā)生產機構（CDMO），是API，新化學分子實體（NCE）和用于仿制藥以及合同生產高級中間體的領先制造商，向全球供應經DMF注冊的約40個API。

憑借600多名技術精湛、高度敬業(yè)的員工，得益于美國和意大利的四家最高水平的cGMP制造工廠，以及位于意大利、美國和中國的商業(yè)銷售網(wǎng)絡，Dipharma在戰(zhàn)略上定位于滿足制藥行業(yè)的動態(tài)需求。

在內部知識產權部門的配合下，我們設備齊全的研發(fā)中心，通過開發(fā)量身定制的尖端化學工藝和晶型來推動創(chuàng)新，以滿足客戶的獨特需求。

自1970年以來，Dipharma在主要監(jiān)管機構的不間斷檢查中一直保持良好的記錄，它的cGMP設施 具備從實驗室到商業(yè)化生產的供應能力，涵蓋了藥物開發(fā)的整個生命周期。

Dipharma的核心技術有:高壓加氫、硝化、亞硝基酯化、疊氮化物化學、硼氫還原、交叉偶聯(lián)反應、庫爾提斯反應、溶解金屬還原、酶化學、環(huán)氧氯丙烷化學、 霍夫曼反應、過氧化氫氧化、糖質化學、對映選擇性反應、硝基烷烴使用(Henry反應)、沃爾夫基斯內爾-還原反應。

Dipharma集團有著適當?shù)囊?guī)模和各類商業(yè)化生產拓展的能力來參與全球的事務，通過有效地流程管理，靈活敏捷的機制，以快速應對市場的各種挑戰(zhàn)。

Dipharma是你值得信賴的合作伙伴。